AAAAAA

   
Results: 1-11 |
Results: 11

Authors: GAEDE KI ZISSEL G SCHWULERA U STRUFF WG LORENZ J AULITZKY WE ZIPFEL P SCHRUM S SCHLAAK M HUBER C MULLERQUERNHEIM J
Citation: Ki. Gaede et al., SPONTANEOUS AND INTERLEUKIN-2-MODULATED CYTOKINE RELEASE BY BRONCHOALVEOLAR CELLS IN PULMONARY MALIGNANCY, European cytokine network, 8(4), 1997, pp. 395-400

Authors: LORENZ J WILHELM K KESSLER M PESCHEL C SCHWULERA U LISSNER R STRUFF WG HULAND E HUBER C AULITZKY WE
Citation: J. Lorenz et al., PHASE-I TRIAL OF INHALED NATURAL INTERLEUKIN-2 FOR TREATMENT OF PULMONARY MALIGNANCY - TOXICITY, PHARMACOKINETICS, AND BIOLOGICAL EFFECTS, Clinical cancer research, 2(7), 1996, pp. 1115-1122

Authors: SCHRODER W SCHWULERA U LISSNER R BENDER HG
Citation: W. Schroder et al., EXPERIMENTAL, PHARMAKOKINETIC AND CLINICA L-EVALUATION OF IP THERAPY WITH INTERLEUKIN-2 (NIL-2) IN PATIENTS WITH OVARIAN-CANCER, Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 46-52

Authors: SCHWAIBOLD H HULAND E HEINZER H SCHWULERA U HULAND H
Citation: H. Schwaibold et al., TOXICITY OF LOCAL, CONTINUOUS AND CYCLIC, HIGH-DOSE BLADDER PERFUSIONWITH RECOMBINANT AND NATURAL INTERLEUKIN-2 IN ADVANCED CANCER OF THE URINARY-BLADDER, Journal of cancer research and clinical oncology, 121(4), 1995, pp. 239-246

Authors: JAHN B BERGMANN L WEIDMANN E BRIEGER J FENCHEL K SCHWULERA U HOELZER D MITROU PS
Citation: B. Jahn et al., BONE-MARROW-DERIVED T-CELL CLONES OBTAINED FROM UNTREATED ACUTE MYELOCYTIC-LEUKEMIA EXHIBIT BLAST DIRECTED AUTOLOGOUS CYTOTOXICITY, Leukemia research, 19(2), 1995, pp. 73-82

Authors: JACHIMCZAK P SCHWULERA U BOGDAHN U
Citation: P. Jachimczak et al., IN-VITRO STUDIES OF CYTOKINE-MEDIATED INTERACTIONS BETWEEN MALIGNANT GLIOMA AND AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Journal of neurosurgery, 81(4), 1994, pp. 579-586

Authors: HLADIK F TRATKIEWICZ JA TILG H VOGEL W SCHWULERA U KRONKE M AULITZKY WE HUBER C
Citation: F. Hladik et al., BIOLOGIC ACTIVITY OF LOW-DOSAGE IL-2 TREATMENT IN-VIVO - MOLECULAR ASSESSMENT OF CYTOKINE NETWORK INTERACTION, The Journal of immunology, 153(4), 1994, pp. 1449-1454

Authors: ROSENER M SCHWULERA U MENKE G THRUN A LISSNER R KRAUSENECK P BOGDAHN U MARTIN R
Citation: M. Rosener et al., TOLERANCE AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF INTRATHECALLY ADMINISTERED HUMAN NATURAL INTERLEUKIN-2 - A PHASE-I TRIAL, European cytokine network, 4(3), 1993, pp. 189-195

Authors: KLINGEMANN HG NEERUNJUN J SCHWULERA U ZILTENER HJ
Citation: Hg. Klingemann et al., CULTURE OF NORMAL AND LEUKEMIC BONE-MARROW IN INTERLEUKIN-2 - ANALYSIS OF CELL ACTIVATION, CELL-PROLIFERATION, AND CYTOKINE PRODUCTION, Leukemia, 7(9), 1993, pp. 1389-1393

Authors: TILG H VOGEL W TRATKIEWICZ J AULITZKY WE HEROLD M GRUBER M GEISSLER D UMLAUFT F JUDMAIER G SCHWULERA U THRUN A HUBER C
Citation: H. Tilg et al., PILOT-STUDY OF NATURAL HUMAN INTERLEUKIN-2 IN PATIENTS WITH CHRONIC HEPATITIS-B - IMMUNOMODULATORY AND ANTIVIRAL EFFECTS, Journal of hepatology, 19(2), 1993, pp. 259-267

Authors: SCHEIDELER L MANKE HG SCHWULERA U INACKER O HAMMERLE H
Citation: L. Scheideler et al., DETECTION OF NONVOLATILE MACROMOLECULES IN BREATH - A POSSIBLE DIAGNOSTIC-TOOL, The American review of respiratory disease, 148(3), 1993, pp. 778-784
Risultati: 1-11 |